|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||26.85 - 27.49|
|52 Week Range||14.22 - 28.35|
|Beta (5Y Monthly)||1.19|
|PE Ratio (TTM)||778.57|
|Forward Dividend & Yield||0.56 (2.03%)|
|Ex-Dividend Date||Sep 28, 2020|
|1y Target Est||N/A|
Hiroaki Nakanishi has been forced to step down as chair of Japan’s Keidanren business lobby after a recurrence of cancer, removing a powerful reformist voice from the top of corporate Japan. The loss of Nakanishi, who won fame for his transformation of Hitachi as chief executive and chair in the 2010s, will be regarded as a setback for the cause of modernisers in Japanese business. Masakazu Tokura, the chair of Sumitomo Chemical, will succeed Nakanishi, following a tradition whereby the Keidanren chief comes from an industrial company.
Japan's Nikkei share average edged lower on Wednesday, tracking Wall Street's overnight losses, as investors monitored a rise in new virus cases across the world that could derail a nascent economic recovery. New coronavirus cases continue to climb globally, with California reporting a record rise for a single day and Australia's second-biggest city Melbourne re-imposing lockdown measures on Tuesday. On the domestic front, capital Tokyo has been registering fresh cases exceeding 100, but Economy Minister Yasutoshi Nishimura said on Wednesday a new state of emergency for the coronavirus is not needed.